Antiviral drugs that target reverse transcriptase

Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Nucleoside reverse transcriptase inhibitors (NRTIs), and nucleotide reverse transcriptase inhibitors (NtRTIs), often all referred to as NRTIs, work by targeting the action of an HIV protein called reverse transcriptase.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are antiviral agents that bind non-competitively to HIV-1's reverse transcriptase and prevents

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are antiviral agents that bind non-competitively to HIV-1's reverse transcriptase and prevents

De novo gene synthesis by an antiviral reverse transcriptase. More target for the treatment of allergic diseases. A deeper

An ideal antimicrobial therapeutic drug exhibits all of the following characteristics except Antiviral drugs that target reverse transcriptase would be

Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H Curr Med Chem . 2024;29(10): . doi: 10.2174/ .

Reverse transcriptase of HIV as a target for anti-viral drugs. Reverse transcriptase of HIV as a target for anti-viral drugs. Antiviral Agents / pharmacology

It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases

HIV reverse transcriptase (RT) is the target of a number of important anti-AIDS drugs. Drugs that inhibit RT are either nucleoside reverse transcriptase inhibitors (NRTIs) or non-nucleoside reverse transcriptase inhibitors (NNRTIs). Combinations of various anti-AIDS drugs (highly active anti-retrovi